Glioma difuso de línea media H3K27M positivo en adulto. Caso clínico

• Autores: Patricio Araneda, Emi Sujima, Patricio Paredes Manzo, Rodrigo Vallejo, Dr. Felipe Valdivia, Mariana Sinning, Marcela Gallegos Angulo, Gregory Fuller
• Localización: Revista Médica de Chile, ISSN-e 0034-9887, Vol. 147, Nº. 11, 2019, págs. 1487-1490
• Idioma: español
• Títulos paralelos:
  • H3K27 positive diffuse midline glioma. Report of one case
• Enlaces
  • Texto completo
• Resumen

  • The 2016 WHO Classification of Tumours of the Central Nervous System incorporates a new diagnostic entity: the mutant diffuse midline glioma H3K27, a tumor with a characteristic location and special molecular biology. We report the case of a 51-year-old male patient with progressive diplopia. The imaging study showed a mesencephalic tumor; the stereotacic biopsy disclosed an Anaplastic Astrocytoma Isocitrate dehydrogenase (IDH) wild type. The molecular study concludes H3K27 mutation. The patient was treated with radiotherapy with concurrent and adjuvant chemotherapy (temozolomide) with partial recovery of the diplopia.